Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of September 2025, specifically reporting on a transaction dated September 23, 2025. The filing serves as a notification under Article 19 of the UK Market Abuse Regulation regarding shareholdings of a Person Discharging Managerial Responsibility (PDMR).
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, or debt metrics. It reports solely on a specific equity transaction:
- Transaction Type: Acquisition of shares via the Dividend Reinvestment Plan (DRIP).
- Volume: 8,997 ordinary shares of 1 pence each.
- Price per Share: £3.616967.
- Total Transaction Value: £32,541.85.
- Exchange: London Stock Exchange (XLON).
Material Changes
The filing does not provide comparative financial data or discuss material changes to the company's operations or financial position versus prior periods. The only reported change is the increase in shareholding for the specific executive detailed below.
Management Commentary and Risks
Management Commentary: The filing identifies Andy Ransom, the Chief Executive, as the individual who acquired the shares. The transaction was executed automatically through the Company's Dividend Reinvestment Plan.
Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this filing. The document is a routine regulatory notification of insider shareholding changes.
Investor Verification Checklist
- Verify the current total shareholding of Andy Ransom to assess the significance of this 8,997 share acquisition relative to his total holdings.
- Confirm the current market price of Rentokil Initial plc shares to compare against the DRIP purchase price of £3.616967.
- Review the company's latest Form 20-F for comprehensive financial performance data, as this Form 6-K contains no financial results.